Últimas noticias sobre Veritone (NASDAQ:VERI) Bolsa

VERITONE INC

Veritone

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Veritone Inc

Veritaseum

VERI MEDTECH HOLDINGS INC by Veri Medtech Holdings Inc.

Veri Medtech Holdings Inc

VeriDocGlobal

VeriSign Inc

Vericel Corp

Verici Dx PLC

Vericity Inc

VERIDIS ENVIRONMENT LTD by Veridis Environment Ltd.

Veridis Environment Ltd

Verify Smart Corp

VerifyMe Inc

Verimatrix

Verint Systems Inc

Veris Residential Inc

VERISANTE TECHNOLOGY INC by Verisante Technology, Inc.

Verisante Technology Inc

Verisk Analytics Inc

Veritas Farms Inc

Veritec Inc

Veritex Holdings Inc

Veritiv Corp Com

Verity Resources Ltd

Verizon Communications Inc

Vodafone Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOD#NASDAQ">VOD</a>) Vi (Vodafone Idea) and AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) announced a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45991304/vi-and-ast-spacemobile-announce-partnership-for-satellite-connectivity" rel="noreferrer noopener">strategic partnership on</a> Wednesday to expand mobile connectivity across India&#8217;s unconnected regions.
This collaboration will leverage AST SpaceMobile&#8217;s groundbreaking technology, which recently demonstrated successful voice and video calls from space using a standard mobile phone.
While India boasts over 1.1 billion mobile subscribers and extensive 4G and emerging 5G networks, satellite communication will prove crucial in expanding broadband cellular access to challenging terrains.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/space/25/04/45046112/ast-spacemobile-partners-with-us-science-foundation-to-protect-astronomy-observations-while-expanding-satellite-network" rel="noreferrer noopener">AST SpaceMobile Partners With US Science Foundation To Protect Astronomy Observations While Expanding Satellite Network</a>
This partnership will combine Vi&#8217;s national network with AST SpaceMobile&#8217;s revolutionary space-based cellular technology. This technology connects directly to smartphones without specialized software, device support, or updates.
Aligned with Digital India&#8217;s initiatives, AST SpaceMobile and Vodafone Idea will collaborate on the SpaceMobile Satellite System.
The space-based cellular broadband ecosystem will be designed to expand Vi&#8217;s terrestrial connectivity telecom services, providing voice, video, data streaming, and internet access.
It will encompass the design, implementation, and launch of this system, wherein AST SpaceMobile will develop, manufacture, and manage the satellite constellation, and Vi will oversee terrestrial network integration, operating spectrum, and market access.
This announcement comes on the heels of other significant developments in India&#8217;s satellite internet landscape, including Elon Musk&#8217;s SpaceX <a target="_blank" href="https://www.benzinga.com/general/space/25/03/44244377/elon-musks-spacex-partners-with-airtel-to-launch-starlink-in-india-weeks-after-pm-narendra-modis-us-visit" rel="noreferrer noopener">partnering with Indian telecom company</a> Bharti Airtel in March to offer Starlink satellite internet services.
India&#8217;s Department of Telecommunications had requested&nbsp;security assurances&nbsp;from satellite communication providers like Starlink and Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
Starlink and Amazon&#8217;s Project Kuiper&nbsp;have also advocated for reduced spectrum charges and long-term licenses to make satellite services more affordable for Indian consumers.
ASTS&nbsp;Price Action: ASTS stock is trading higher by 3.39% to $41.46 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/24/12/42536024/taiwan-eyes-amazons-kuiper-as-starlink-faces-hurdles" target="_blank" rel="noreferrer noopener">Amazon&#8217;s Project Kuiper In Talks With Taiwan For Satellite Partnership</a></li>
</ul>
Photo via Shutterstock

Asia

News

Movers

Tech

AMZN

ASTS

Vodafone, AST SpaceMobile Partner To Bring Satellite Phone Service To Remote Parts Of India

LITM

Snow Lake Completes 2,719 Meters Of RC Drilling At Engo Valley With 8 Of 31 Holes Returning Significant Uranium Mineralization

Rosenblatt analyst Kevin Cassidy maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Buy and maintains $124 price target.

Price Target

Analyst Ratings

MRVL

Rosenblatt Maintains Buy on Marvell Tech, Maintains $124 Price Target

AXSM

Axsome Says It Will Present SYMBRAVO Migraine Treatment Data From Multiple Trials At AHS 2025 Annual Meeting

President Donald Trump met with Canadian Prime Minister Mark Carney on the sidelines of the G7 summit in Kananaskis, Alberta, on Monday. The media anticipated the conversation to clarify the tense U.S.-Canada relations, which have been strained over tariff escalations and a repeated proposal to <a target="_blank" href="https://www.benzinga.com/25/02/43582659/trump-says-canada-much-better-off-being-the-51st-state-the-border-with-us-is-just-a-line" rel="noreferrer noopener">annex the country as the 51st state</a>.
However, Carney's election in April promised to rebuild a more equal partnership between Ottawa and Washington, shifting the narrative to one of a more pragmatic nature.
"I'm a tariff person," Trump said in a <a target="_blank" href="https://www.youtube.com/watch?v=azGiHYbeiTU" rel="noreferrer noopener">video</a> posted by the Associated Press, explaining his stance on trade.&nbsp;"It's simple, it's easy, it's precise," he added, noting that Carney had "a different concept" but that they would explore both approaches.
Despite their differing philosophies, Trump confirmed a deal was "achievable" within weeks, hinting at openness to negotiation.
Josh Lipsky of the Atlantic Council's GeoEconomics Center reflected on the cautiously optimistic meeting.
"Is it tense? Yes. Is it awkward? Yes. The vibe would be best described as, ‘Let's just get through this.' Everyone is there, and everyone doesn't want a major dust-up," he said <a target="_blank" href="https://www.nytimes.com/2025/06/16/world/canada/canada-g7-trump-carney.html" rel="noreferrer noopener">per</a> the NY Times.
Journalists pressed Trump on key issues, including what was preventing a trade deal. Trump noted active talks between the two parties before turning to criticize former President Barack Obama and former Canadian Prime Minister Justin Trudeau for their role in removing Russia from (what was once) the G8.
"That was a big mistake," Trump said. "You wouldn't have a war right now if Russia had been at the table. If I were president four years ago, you wouldn't have this war."
He also responded to a question about China's inclusion in the G7, calling it "not a bad idea," but clarified that one needs partners with whom they can discuss matters.
The biggest elephant in the room was probably the ongoing conflict between Israel and Iran. When asked about potential U.S. military involvement, he refused to comment.
However, he noted that there was further action to be taken. "They (Iran) want to make a deal …And as soon as I leave here, we're going to be doing something. But I have to leave here," suggesting imminent developments.
Trump and Carney agreed to pursue further negotiations and a potential deal over the next 30 days before Trump cut the visit short and returned to Washington.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/06/45972264/senate-advances-stablecoin-bill-a-defining-moment-for-crypto-market-regulation" target="_blank" rel="noreferrer noopener">Senate Advances Stablecoin Bill: A Defining Moment For Crypto Market Regulation</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Media

BBCA

FLCA

ITOT

Trump Cuts G7 Visit Short, Calls Canada Deal 'Achievable'

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Western Copper &amp; Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WRN#AMEX">WRN</a>) with a Buy and lowers the price target from $4.25 to $4.

HC Wainwright & Co. Maintains Buy on Western Copper & Gold, Lowers Price Target to $4

New offering delivers convenient, comprehensive lab testing solutions for functional medicine, integrative medicine and primary care providers
BURLINGTON, N.C., June 18, 2025 /PRNewswire/ -- Labcorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>), a global leader of innovative and comprehensive laboratory services, announced today the launch of <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4451797-1&amp;h=670611564&amp;u=https%3A%2F%2Fwww.labcorp.com%2Fproviders%2Fwhole-health-solutions&amp;a=Labcorp+Whole+Health+Solutions">Labcorp Whole Health Solutions</a>&nbsp;to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.

Laboratory Corporation Of America Holdings

Labcorp Launches Labcorp Whole Health Solutions To Expand Holistic Care Offerings

INGR

Univar Solutions Expands Ingredion Partnership To Distribute Food Ingredients Across Benelux Region

NVDA

Nvidia Stock Could Rise Another 38%, Making Jensen Huang-Led AI Giant A Nearly $5 Trillion Company, Says Barclays

Scholar Rock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and additional severe and debilitating neuromuscular diseases, today announced positive results from the Phase 2 EMBRAZE proof-of-concept trial assessing apitegromab in combination with tirzepatide to preserve lean mass during tirzepatide-induced weight loss. The trial demonstrated that 30% of total weight loss with tirzepatide alone was due to lean mass loss. Apitegromab therapy (10 mg/kg) with tirzepatide preserved an additional 4.2 pounds (1.9 kilograms) or 54.9% (p=0.001) of lean mass compared to tirzepatide alone, leading to higher quality weight loss. Apitegromab with tirzepatide was generally well tolerated by participants.
"GLP therapies have been an effective and important innovation for individuals living with obesity and cardiometabolic disorders; however, these treatments can result in substantial loss of lean muscle mass for patients, leading to unwanted health risks," said Akshay Vaishnaw, M.D., Ph.D., President of R&amp;D, Scholar Rock. "We are pleased that the EMBRAZE trial accomplished its objective by achieving its primary endpoint. The results validated our hypothesis that our platform of highly selective myostatin inhibitors has the potential to support healthier weight loss for millions of patients on GLP therapies by safely preserving lean mass."
Dr. Vaishnaw added, "While this is an exciting development for our platform, we remain focused on preparing for the launch of apitegromab, and following its potential approval in SMA, we look forward to studying it in a range of neuromuscular diseases with high unmet need. Further, there is great potential with SRK-439 to be a subcutaneous, anti-myostatin antibody and we look forward to also exploring its potential in various rare, severe debilitating neuromuscular disorders. We remain on track to file an IND application for SRK-439 in the second half of this year to support the first in human study."
The EMBRAZE trial was designed to assess the ability to preserve lean body mass associated with tirzepatide-induced weight loss in patients with obesity (BMI of ≥30.0 kg/m2) or overweight (BMI≥27.0 kg/m2 with one or more weight-related co-morbidities). Treatment was administered over a 24-week period, and patients were randomized into two treatment arms: apitegromab with tirzepatide and placebo with tirzepatide.
Topline results successfully demonstrated proof-of-concept for a highly selective, anti-myostatin antibody to preserve lean mass, thus improving quality of weight loss with tirzepatide therapy.

SRRK

Scholar Rock Study Shows New Drug Combo Preserves Muscle During Tirzepatide Weight Loss

3D Systems Issues $92M In Convertible Senior Secured Notes Due 2030 And Retires $180M Of 2026 Notes

D. Boral Capital analyst Jesse Sobelson maintains EON Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EONR#AMEX">EONR</a>) with a Buy and maintains $2 price target.

EONR

D. Boral Capital Maintains Buy on EON Resources, Maintains $2 Price Target

Biotech

Large Cap

Health Care

General

Daiichi Sankyo And Merck Announced The First Patient Has Been Dosed In IDeate-Prostate01 Phase 3 Trial Of Ifinatamab Deruxtecan Versus Docetaxel In Patients With Metastatic Castration-resistant Prostate Cancer With Disease Progression During Or After Treatment With An Androgen Receptor Pathway Inhibitor

BMEA

Biomea Fusion Announces Preclinical Findings From Study Evaluating BMF-650, Showing Dose-Dependent, Marked Reductions In Food Intake And Weight Loss Observed In Obese Cynomolgus Monkeys

CLMB

Climb Channel Solutions Forms North American Alliance With Bugcrowd To Expand Access To Crowdsourced Cybersecurity Solutions

MCHP

Microchip Technology Adds dsPIC33AK512MPS512 And dsPIC33AK512MC510 Digital Signal Controller Families To dsPIC33A DSC Product Line

Garmin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>) today announced the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4451151-1&amp;h=3318746050&amp;u=https%3A%2F%2Fwww.garmin.com%2Fen-US%2Fp%2F1650098&amp;a=Index%E2%84%A2+Sleep+Monitor">Index&#x2122; Sleep Monitor</a>, an ultra-comfortable and lightweight smart sleep band that tracks sleep for a more comprehensive view of overall fitness and recovery. Featuring up to 7 nights of battery life with continuous Pulse Ox tracking, the Index Sleep Monitor is worn on the upper arm and tracks sleep stages, heart rate variability (HRV) status, breathing variations, skin temperature and more to calculate a sleep score for users and provide valuable insights about their health1. After a night of sleep, the data seamlessly syncs to the Garmin Connect&#x2122; smartphone app and can be combined with metrics from a compatible Garmin smartwatch to fill in gaps in data for users who don't wear their watch at night or are looking to better understand how well they recovered.
 &nbsp;

GRMN

Garmin Launches Smart Sleep Band That Tracks Breathing, Heart Rate, and Recovery While You Sleep

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $16 price target.

D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $16 Price Target

MLEC

Moolec Gains Core US Patent Protecting Piggy Sooy As First Engineered Soybean With Porcine Hemeproteins And Major Sustainability Advantages

Rafael Holdings Says Phase 3 Study Of Trappsol Cyclo In Niemann-Pick Disease Type C1 Treatment Wil Continue Based On Data Monitoring Committee Review Of Prespecified 48-Week Interim Data

Press Releases

Carahsoft Canada Awarded Veritone Supply Arrangement for SaaS Under the Government of Canada Cloud Initiative

Veritone to Showcase AI Solutions that Help Content Owners Transform Unstructured Media Into Revenue Generating Assets at NAB 2025

Veritone Wins Future's Best of Show Award at the 2025 NAB Show

Veritone Achieves "Awardable" Status on DoD's Tradewinds Solutions Marketplace with AI-Powered Investigate Solution

Veritone Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Veritone Teams Up with Technology North to Modernize Public Safety Redaction Efforts Using AI

Veritone to Hold First Quarter 2025 Results Conference Call on May 8th

Veritone to Participate in J.P. Morgan's 53rd Annual Global Technology, Media and Communications Conference

Veritone Reports First Quarter 2025 Results

Veritone Signs Agreement with Riverside County Sheriff's Office for AI Redaction Technology

VERI

ACCESS Newswire

AudioEye

Aware

BeLive Holdings

BTCS

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

Comments

Veritone

Noticias

Últimas noticias sobre Veritone (NASDAQ:VERI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL